A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/29/2002	CA2094481C Processes for the preparation of amylase inhibitor
10/29/2002	CA2090515C Anti-feline calicivirus recombinant antibody and gene fragment encoding the same
10/29/2002	CA2063431C Receptors for fibroblast growth factors
10/29/2002	CA2060034C Tumour growth-inhibiting somatostatin analogues, pharmaceutical compositions containing them and process for preparing same
10/29/2002	CA2045552C Cancer related haptoglobin
10/29/2002	CA2033969C Albumin preparation and process for producing same
10/28/2002	EP1009417A4 Dietary supplements containing natural ingredients
10/28/2002	EP0831872A4 Polypeptide compounds that form beta sheets
10/24/2002	WO2002084297A1 Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders
10/24/2002	WO2002084294A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/24/2002	WO2002083956A1 Compositions and methods for the therapy and diagnosis of breast cancer
10/24/2002	WO2002083950A1 Methods and compositions for treating cardiovascular disease using 10218
10/24/2002	WO2002083946A1 Method of examining allergic disease
10/24/2002	WO2002083945A2 Diagnosis and treatment of cancer: i
10/24/2002	WO2002083929A2 System and method for quantitating transcription factors
10/24/2002	WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002	WO2002083926A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	WO2002083921A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	WO2002083919A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002	WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	WO2002083915A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/24/2002	WO2002083914A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/24/2002	WO2002083902A2 Adenovirus serotype 30 (ad30) fiber protein and uses thereof
10/24/2002	WO2002083900A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/24/2002	WO2002083898A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	WO2002083891A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
10/24/2002	WO2002083877A1 Production of tyrosine hydroxylase positive neurons
10/24/2002	WO2002083874A2 Endothelial cell expression patterns
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083866A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
10/24/2002	WO2002083860A2 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/24/2002	WO2002083858A2 Methods to inhibit viral replication
10/24/2002	WO2002083857A2 68723, sodium/glucose cotransporter family members and uses therefor
10/24/2002	WO2002083856A2 Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
10/24/2002	WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	WO2002083851A2 Vegf fusion proteins
10/24/2002	WO2002083841A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083734A2 Modified calcitonin
10/24/2002	WO2002083733A2 Polynucleotides and polypeptides of the ifnalpha-6 gene
10/24/2002	WO2002083729A2 Polypeptides derived from amyloid precursor peptide (app) and their uses
10/24/2002	WO2002083728A2 Splice variant
10/24/2002	WO2002083727A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid
10/24/2002	WO2002083726A2 A novel zinc finger protein and uses thereof
10/24/2002	WO2002083723A2 Polypeptides from h. influenzae homologous to a surface-exposed protein of neisseria meningitidis
10/24/2002	WO2002083722A2 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides
10/24/2002	WO2002083716A2 Type b botulism toxin inhibitors
10/24/2002	WO2002083715A1 Method and apparatus for fractional separation of proteins from plant material
10/24/2002	WO2002083713A2 Echinocandin process
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083705A1 Socs-1 gene methylation in cancer
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083241A1 Single dose aromatase inhibitor for treating infertility
10/24/2002	WO2002083240A1 Aromatase inhibition to enhance assisted reproduction
10/24/2002	WO2002083239A1 Aromatase inhibitors for treating infertility
10/24/2002	WO2002083186A1 Nuclear receptor-mediated introduction of a pna into cell nuclei
10/24/2002	WO2002083185A1 Method of gene transfer via vascular system or ureter
10/24/2002	WO2002083184A2 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
10/24/2002	WO2002083182A2 The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification
10/24/2002	WO2002083180A1 Elongated and multiple spacers in activatible prodrugs
10/24/2002	WO2002083179A2 Fusion proteins
10/24/2002	WO2002083176A2 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
10/24/2002	WO2002083170A1 Vaccines including as an adjuvant type 1 ifn and processes related thereto
10/24/2002	WO2002083168A1 Enzymes combination coadjuvating in the interferon therapy
10/24/2002	WO2002083167A2 Therapeutic compositions for the treatment of a respiratory tract disease
10/24/2002	WO2002083165A1 Stable preparations for injection
10/24/2002	WO2002083164A2 Method and composition for prophylaxis of diabetes
10/24/2002	WO2002083163A1 The use of the protein uk114 for the treatment and the prevention of chronic active hepatitis
10/24/2002	WO2002083162A1 Use of a cd8+ t cell inhibitory agent in the presence of a cd4+ t cell inhibitory agent for inhibition of transplant rejection
10/24/2002	WO2002083161A1 Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock
10/24/2002	WO2002083146A1 Multiple dose aromatase inhibitor for treating infertility
10/24/2002	WO2002083137A1 Use of npy y2 receptor antagonists
10/24/2002	WO2002083120A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
10/24/2002	WO2002083103A2 Pharmaceutical product with reticulated crystalline microstructure
10/24/2002	WO2002083096A1 Modification of the sustained release profile
10/24/2002	WO2002083088A1 Methods of preventing uvb-induced skin damage
10/24/2002	WO2002083081A2 Prostate cancer-related compositions, methods and kits based on dna macroarray protemics platforms
10/24/2002	WO2002083076A2 Method for inhibiting atherosclerotic plaque formation
10/24/2002	WO2002083074A2 Methods for the treatment of hepatic disorders
10/24/2002	WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002	WO2002083065A2 Peptide antiangiogenic drugs
10/24/2002	WO2002083063A2 Method of improving systemic exposure of subcutaneously administered therapeutic proteins
10/24/2002	WO2002083060A2 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
10/24/2002	WO2002083030A2 Bifunctional energy-reversible acyl-compositions
10/24/2002	WO2002082904A2 Method of treating or retarding the development of blindness
10/24/2002	WO2002066078A3 Modulated release particles for aerosol delivery
10/24/2002	WO2002066077A3 Modulated release particles for aerosol delivery
10/24/2002	WO2002064023A3 Fra-1 expression in brain cancer
10/24/2002	WO2002062951A3 Antisense modulation of casein kinase 2-alpha prime expression
10/24/2002	WO2002061061A3 Inhibition of interleukin-1-beta secretion by card proteins
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002058714A3 Methods and agents modulating upa/upar activity
10/24/2002	WO2002055669A3 Regulation of target protein activity through modified proteins
10/24/2002	WO2002046367A3 Antisense modulation of cellular apoptosis susceptibility gene expression
10/24/2002	WO2002040715A8 Molecules for disease detection and treatment
10/24/2002	WO2002040038A3 M. tuberculosis chaperonin 10 and uses thereof
10/24/2002	WO2002034896A3 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
10/24/2002	WO2002032397A9 Electroprocessing in drug delivery and cell encapsulation

1 ... 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 ... 3163